| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluation
|
Akerley, Wallace
|
|
2013
|
79 |
3 |
p. 307-311
5 p.
|
artikel
|
| 2 |
A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)
|
Kim, Se Hyun
|
|
2013
|
79 |
3 |
p. 270-275
6 p.
|
artikel
|
| 3 |
Contents
|
|
|
2013
|
79 |
3 |
p. v-vi
nvt p.
|
artikel
|
| 4 |
Continued treatment with gefitinib beyond progressive disease benefits patients with activating EGFR mutations
|
Asami, Kazuhiro
|
|
2013
|
79 |
3 |
p. 276-282
7 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2013
|
79 |
3 |
p. iii-
1 p.
|
artikel
|
| 6 |
Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery
|
Ahn, Hee Kyung
|
|
2013
|
79 |
3 |
p. 300-306
7 p.
|
artikel
|
| 7 |
Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer
|
Takeda, Atsuya
|
|
2013
|
79 |
3 |
p. 248-253
6 p.
|
artikel
|
| 8 |
Family history of lung cancer in never smokers with non-small-cell lung cancer and its association with tumors harboring EGFR mutations
|
Gaughan, Elizabeth M.
|
|
2013
|
79 |
3 |
p. 193-197
5 p.
|
artikel
|
| 9 |
Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer
|
Grob, Tobias J.
|
|
2013
|
79 |
3 |
p. 221-227
7 p.
|
artikel
|
| 10 |
Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer
|
Park, Jong Y.
|
|
2013
|
79 |
3 |
p. 198-204
7 p.
|
artikel
|
| 11 |
Human papilloma virus genome is rare in North American non-small cell lung carcinoma patients
|
Yanagawa, Naoki
|
|
2013
|
79 |
3 |
p. 215-220
6 p.
|
artikel
|
| 12 |
Lung cancer and pregnancy
|
Sarıman, Nesrin
|
|
2013
|
79 |
3 |
p. 321-323
3 p.
|
artikel
|
| 13 |
Messenger RNA and protein expression of thymidylate synthase and DNA repair genes in thymic tumors
|
Monica, Valentina
|
|
2013
|
79 |
3 |
p. 228-235
8 p.
|
artikel
|
| 14 |
Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT
|
Choi, Hongyoon
|
|
2013
|
79 |
3 |
p. 242-247
6 p.
|
artikel
|
| 15 |
Primary lung adenocarcinoma occurring in a PTEN related syndrome (Cowden's disease): Routine EGFR sequencing also highlights two rare somatic mutations S768I and V769L
|
Boespflug, Amélie
|
|
2013
|
79 |
3 |
p. 318-320
3 p.
|
artikel
|
| 16 |
Prognostic role of clusterin in resected adenocarcinomas of the lung
|
Panico, Francesca
|
|
2013
|
79 |
3 |
p. 294-299
6 p.
|
artikel
|
| 17 |
Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitors
|
Nishino, Mizuki
|
|
2013
|
79 |
3 |
p. 283-288
6 p.
|
artikel
|
| 18 |
Randomized phase II trial of sulindac for lung cancer chemoprevention
|
Limburg, Paul J.
|
|
2013
|
79 |
3 |
p. 254-261
8 p.
|
artikel
|
| 19 |
Reproducibility of the WHO classification of thymomas: Practical implications
|
Zucali, P.A.
|
|
2013
|
79 |
3 |
p. 236-241
6 p.
|
artikel
|
| 20 |
Socioeconomic position and surgery for early-stage non-small-cell lung cancer: A population-based study in Denmark
|
Starr, Laila Kærgaard
|
|
2013
|
79 |
3 |
p. 262-269
8 p.
|
artikel
|
| 21 |
The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
|
Nygaard, Anneli Dowler
|
|
2013
|
79 |
3 |
p. 312-317
6 p.
|
artikel
|
| 22 |
Treatment, prognostic markers and survival in thymic neuroendocrine tumours. A study from a single tertiary referral centre
|
Crona, Joakim
|
|
2013
|
79 |
3 |
p. 289-293
5 p.
|
artikel
|
| 23 |
TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma
|
Odate, Seiichi
|
|
2013
|
79 |
3 |
p. 205-214
10 p.
|
artikel
|
Tijdschrift beschrijving